Celldex Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $474k | 18k | 25.89 |
| 2025-03-31 | $1.1M | 62k | 18.15 |
| 2024-09-30 | $548k | 16k | 34.01 |
| 2024-06-30 | $205k | 5.5k | 37.05 |
| 2024-03-31 | $296k | 7.0k | 42.04 |
| 2023-09-30 | $1.2M | 45k | 27.53 |
| 2023-06-30 | $520k | 15k | 33.96 |
| 2023-03-31 | $897k | 25k | 35.96 |
| 2022-09-30 | $312k | 11k | 28.07 |
| 2021-12-31 | $724k | 19k | 38.66 |
| 2021-06-30 | $327k | 9.8k | 33.47 |